Squarepoint’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,200
Closed -$203K 4594
2025
Q4
$203K Buy
+2,200
New +$210K ﹤0.01% 3861
2024
Q4
Sell
-15,600
Closed -$3.29M 5256
2024
Q3
$3.29M Sell
15,600
-4,500
-22% -$782K 0.01% 1725
2024
Q2
$2.69M Sell
20,100
-39,500
-66% -$7.48M ﹤0.01% 1823
2024
Q1
$12.8M Buy
+59,600
New +$11.7M 0.02% 855
2023
Q1
Sell
-900
Closed -$227K 3480
2022
Q4
$227K Buy
+900
New +$192K ﹤0.01% 2720

Other funds holding INSP

Squarepoint's INSP Position: Q2 2026 in Review

Squarepoint reduced its Inspire Medical Systems (INSP) stake by 64% in Q2 2026, selling an estimated $2.02M and leaving 24,259 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2842.

Squarepoint first reported a position in INSP in Q1 2019 and has held it in 24 quarters since. The position peaked at $11.1M in Q3 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Squarepoint held 24,259 shares of Inspire Medical Systems worth $1.08M as of Q2 2026.
  • Squarepoint sold 42,555 Inspire Medical Systems shares in Q2 2026, an estimated $2.02M.
  • Inspire Medical Systems made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2842 holding.
  • Squarepoint first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 24 quarters since.
  • Squarepoint's Inspire Medical Systems position peaked at $11.1M in Q3 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.